poisar

Stocks · News reference

Target, Truist Financial And More On CNBC’s ‘Final Trades’

BenzingaAvi Kapoor

CNBC’s final trades: Joshua Brown picks Target, Stephanie Link chooses Truist Financial, and Shannon Saccocia recommends iShares U.S. Healthcare ETF.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolBrendan Coffey

    Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

    The article compares two healthcare-focused ETFs from iShares: IHE (Pharmaceuticals ETF) with 55 holdings and IYH (Healthcare ETF) with 100 holdings. While IHE delivered stronger 1-year returns of 50% versus IYH's 27.4%, the article recommends IYH as the better choice due to superior 3- and 5-year performance, greater diversification, and larger asset base of $3.9B. Both funds have identical 0.37% expense ratios.

  2. The Motley FoolAdria Cimino

    This Unassuming Stock is Trouncing Nvidia in 2026. Here’s Why It’s a No-Brainer Buy.

    Target has climbed nearly 60% in 2026, outperforming Nvidia's 17% gain. Under new CEO Michael Fiddelke, Target is executing a turnaround strategy focused on employee training, store redesigns, and AI-driven shopping improvements. The retailer is showing early success with 3.6% traffic growth and strong performance in food, beverage, and beauty categories. As a Dividend King with 50+ consecutive years of dividend increases and $4.5 billion in free cash flow, Target offers both growth potential and passive income.

  3. Zacks Investment ResearchNa

    Can Macy's Raised 2026 Outlook Offset Third-Quarter Earnings Risk?

    Macy's raised its 2026 EPS guidance to $2.15-$2.35 following strong Q2 results with 2.7% comparable sales growth and 14% adjusted earnings increase. However, the company expects Q3 adjusted earnings losses of 19-23 cents per share due to heavy reinvestment and tough year-over-year comparisons, though lower tariff pressure and supply-chain efficiencies should support margins.